Oxeclosporin

DB21134ExperimentalSmall molecule

Oxeclosporin is a small molecule drug. The usage of the INN stem '-(clo)sporin' in the name indicates that Oxeclosporin is a cyclosporine derivative. Oxeclosporin has a monoisotopic molecular weight of...

Formula / weight: C₆₄H₁₁₅N₁₁O₁₄ · 1262.687 g/mol (avg)
Code names: IMM-125 · SDZ-IMM-125

Resolves to

Compound

UNIIR7988D03JMCAS135548-15-1ChEMBLCHEMBL217642

Structure

InChIKeyXZDDMPMZGYEESG-VNHFGJPGSA-NSMILES

[H][C@@]1([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](COCCO)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C(=O)[C@H](CC)NC1=O)C(C)C

What you can answer from here — as of September 16, 2026

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of Oxeclosporin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account